Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Short Interest Up 439.5% in January

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) saw a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,760,000 shares, an increase of 439.5% from the January 15th total of 326,200 shares. Approximately 4.8% of the shares of the company are short sold. Based on an average trading volume of 6,950,000 shares, the short-interest ratio is presently 0.3 days.

Cardio Diagnostics Price Performance

NASDAQ CDIO traded up $0.01 during trading hours on Wednesday, hitting $0.54. The company had a trading volume of 1,007,014 shares, compared to its average volume of 3,571,226. Cardio Diagnostics has a fifty-two week low of $0.19 and a fifty-two week high of $1.91. The business has a fifty day simple moving average of $0.73 and a 200-day simple moving average of $0.46.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.